Transcode Therapeutics Inc logo

Transcode Therapeutics Inc share price today

(RNAZ)

Transcode Therapeutics Inc share price is $8.7 & ₹736.39 as on 6 Dec 2024, 2.30 'hrs' IST

$8.7

-1.05

(-10.77%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Transcode Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Transcode Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Transcode Therapeutics Inc. Get details on the Indian mutual funds that are investing in Transcode Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Transcode Therapeutics Inc's financials.

Transcode Therapeutics Inc share price movements

  • $8.65
    $9.40

    Day's Volatility :7.93%

  • $7.13
    $306.11

    52 Weeks Volatility :97.67%

Transcode Therapeutics Inc Returns

PeriodTranscode Therapeutics IncIndex (Russel 2000)
3 Months
-0.18%
0.0%
6 Months
-76.03%
0.0%
1 Year
-96.72%
0.0%
3 Years
-99.99%
-19.7%

Transcode Therapeutics Inc Key Statistics

in dollars & INR

Previous Close
$9.75
Open
$9.19
Today's High
$9.395
Today's Low
$8.65
Market Capitalization
$6.8M
Today's Volume
$43.3K
52 Week High
$306.108
52 Week Low
$7.128
Revenue TTM
$0.0
EBITDA
$-17.7M
Earnings Per Share (EPS)
$6014.58
PE Ratio
0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1048.7%

How to invest in Transcode Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Transcode Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Transcode Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Transcode Therapeutics Inc or RNAZ on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Transcode Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Transcode Therapeutics Inc shares which would translate to 0.097 fractional shares of Transcode Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Transcode Therapeutics Inc

17%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Transcode Therapeutics Inc on INDmoney from India has grown in the last 30 days as on Dec 6, 2024. 17% more investors are searching Transcode Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Transcode Therapeutics Inc

  • Geode Capital Management, LLC

    0.71%

  • PRIVATE CAPITAL MANAGEMENT LLC

    0.47%

  • Sheets Smith Wealth Management

    0.29%

  • Virtu Financial LLC

    0.11%

  • Ronna Sue Cohen

    0.10%

  • CapTrust Financial Advisors

    0.07%

Analyst Recommendation on Transcode Therapeutics Inc

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Transcode Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Transcode Therapeutics Inc

What analysts predicted

Upside of 1037.93%

Current:

$8.70

Target:

$99.00

Insights on Transcode Therapeutics Inc

  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 43.9% return, outperforming this stock by 141.0%
  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.3% return, outperforming this stock by 142.3%

Transcode Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Transcode Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.

Transcode Therapeutics Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Transcode Therapeutics Inc
-43.79%
-76.03%
-96.72%
-99.99%
-99.99%
Regeneron Pharmaceuticals, Inc.
-5.97%
-23.44%
-9.57%
20.91%
110.02%
Biontech Se
11.44%
18.44%
16.6%
-60.74%
309.79%
Alnylam Pharmaceuticals, Inc.
-7.77%
64.82%
42.06%
39.68%
108.61%
Vertex Pharmaceuticals Incorporated
-6.83%
-4.79%
29.94%
124.11%
109.65%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Transcode Therapeutics Inc
0.0
0.0
NA
-60.72
-10.49
-2.08
NA
2.62
Regeneron Pharmaceuticals, Inc.
18.56
18.56
1.12
44.92
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.21
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Transcode Therapeutics Inc
Buy
$6.8M
-99.99%
0.0
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$82.9B
110.02%
18.56
33.61%
Biontech Se
Buy
$28.5B
309.79%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
108.61%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$118.4B
109.65%
32.84
-4.51%

About Transcode Therapeutics Inc

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.
Organization
Transcode Therapeutics Inc
Employees
10
CEO
Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D.
Industry
Miscellaneous

Management People of Transcode Therapeutics Inc

NameTitle
Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D.
Executive Chairman of the Board
Mr. Thomas A. Fitzgerald M.B.A.
Interim CEO, CFO, President, VP of Administration & Director
Dr. Zdravka Medarova Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Anna Moore Ph.D.
Co-Founder, Scientific Advisor & Member of Scientific Advisory Board
Ms. Susan Duggan M.B.A., R.N.
Senior Vice President of Operations
Dr. Daniel R. Vlock M.D.
Chief Medical Officer

Important FAQs about investing in Transcode Therapeutics Inc from India :

What is Transcode Therapeutics Inc share price today?

Transcode Therapeutics Inc (RNAZ) share price today is $8.70.

Can Indians buy Transcode Therapeutics Inc shares?

Yes, Indians can invest in the Transcode Therapeutics Inc (RNAZ) from India.

With INDmoney, you can buy Transcode Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Transcode Therapeutics Inc at zero transaction cost.

How can I buy Transcode Therapeutics Inc shares from India?

It is very easy to buy Transcode Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Transcode Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Transcode Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Transcode Therapeutics Inc stocks?

To start investing in Transcode Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Transcode Therapeutics Inc

Today’s highest price of Transcode Therapeutics Inc (RNAZ) is $9.40.

Today’s lowest price of Transcode Therapeutics Inc (RNAZ) is $8.65.

What is today's market capitalisation of Transcode Therapeutics Inc

Today's market capitalisation of Transcode Therapeutics Inc RNAZ is 6.8M

What is the 52 Week High and Low Range of Transcode Therapeutics Inc

  • 52 Week High

    $306.11

  • 52 Week Low

    $7.13

How much percentage Transcode Therapeutics Inc is down from its 52 Week High?

Transcode Therapeutics Inc (RNAZ) share price is $8.70. It is down by 99% from its 52 Week High price of $306.11.

How much percentage Transcode Therapeutics Inc is up from its 52 Week low?

Transcode Therapeutics Inc (RNAZ) share price is $8.70. It is up by 1% from its 52 Week Low price of $7.13.

What are the historical returns of Transcode Therapeutics Inc?

  • 1 Month Returns

    -43.79%

  • 3 Months Returns

    -76.03%

  • 1 Year Returns

    -96.72%

  • 5 Years Returns

    -99.99%

Who is the Chief Executive Officer (CEO) of Transcode Therapeutics Inc

Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D. is the current Chief Executive Officer (CEO) of Transcode Therapeutics Inc.